Logos Global Management LP Madrigal Pharmaceuticals, Inc. Transaction History

Logos Global Management LP

  • $761 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$231.06 - $307.08 $2.31 Million - $3.07 Million
-10,000 Reduced 16.67%
50,000 $12.1 Million
Q4 2022

Feb 14, 2023
BUY
$58.39 - $296.54 $3.5 Million - $17.8 Million
60,000 New
60,000 $17.4 Million
Q1 2020

May 15, 2020
SELL
$66.76 - $93.49 $1.82 Million - $2.55 Million
-27,279 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$84.28 - $118.5 $2.3 Million - $3.23 Million
27,279 New
27,279 $2.49 Million

Others Institutions Holding MDGL

# of Institutions
337
Shares Held
22.3M
Call Options Held
987K
Put Options Held
960K
View Full List

About MADRIGAL PHARMACEUTICALS, INC.

MDGL Quotes by TradingView
  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.77B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email